1. Home
  2. ABCL vs AVNS Comparison

ABCL vs AVNS Comparison

Compare ABCL & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.97

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Avanos Medical Inc.

AVNS

Avanos Medical Inc.

HOLD

Current Price

$24.90

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
AVNS
Founded
2012
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.2B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
ABCL
AVNS
Price
$5.97
$24.90
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$8.40
N/A
AVG Volume (30 Days)
6.2M
1.2M
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
81.59
EPS
N/A
0.11
Revenue
$75,128,000.00
$701,200,000.00
Revenue This Year
N/A
$3.28
Revenue Next Year
$21.85
$4.23
P/E Ratio
N/A
$226.82
Revenue Growth
160.56
1.95
52 Week Low
$2.75
$9.30
52 Week High
$6.79
$25.49

Technical Indicators

Market Signals
Indicator
ABCL
AVNS
Relative Strength Index (RSI) 60.46 66.44
Support Level $5.23 $24.64
Resistance Level $6.65 $24.91
Average True Range (ATR) 0.52 0.08
MACD -0.01 -0.12
Stochastic Oscillator 56.38 10.87

Price Performance

Historical Comparison
ABCL
AVNS

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.

Share on Social Networks: